4//SEC Filing
Zankel Todd 4
Accession 0001140361-12-022412
CIK 0001070698other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:49 PM ET
Size
14.4 KB
Accession
0001140361-12-022412
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-05-01$5.82/sh−3,929$22,867→ 686,834 total - Exercise/Conversion
Common Stock
2012-05-01$2.83/sh+3,643$10,310→ 690,477 total - Exercise/Conversion
Stock options (right to buy)
2012-05-01+3,643→ 313,136 totalExercise: $2.83From: 2006-11-25Exp: 2016-05-25→ Common Stock (3,643 underlying) - Sale
Common Stock
2012-05-01$5.84/sh−17,484$102,194→ 669,350 total - Exercise/Conversion
Stock options (right to buy)
2012-05-01+286→ 312,850 totalExercise: $2.02From: 2010-03-09Exp: 2020-03-08→ Common Stock (286 underlying) - Exercise/Conversion
Common Stock
2012-05-01$2.02/sh+286$578→ 690,763 total
Footnotes (4)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]Original option grant vests 6/36ths on November 25, 2006 and 1/36th per month thereafter.
- [F3]Original option grant vests 6/48ths on March 9, 2010 and 1/48th per month thereafter.
- [F4]This transaction was executed in multiple trades at prices ranging from $5.77 to $5.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeother
Related Parties
1- filerCIK 0001362490
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:49 PM ET
- Size
- 14.4 KB